InsidersTradesSigma
Explore the complete record of transactions filed by Meyers James R, Directeur. Insider active across 1 company, notably Sangamo Therapeutics, INC. In total, 1 disclosures have been recorded. Activity tracked since 25 February 2022. The latest transaction was filed on 25 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
James R. Meyers is a Director at Sangamo Therapeutics, Inc. He contributes to overseeing the company's activities and making strategic decisions within the board. With significant experience in the biopharmaceutical sector, James provides informed perspectives on the challenges and opportunities the company faces. His commitment to corporate governance is an asset to Sangamo.